Illuminating Breast Cancer Recurrence Risk  |   > Search     |   Take me to: Genomic Health - Home Oncotype - Home Healthcare Professionals Patients and Caregivers Oncotype DX Logistics About Oncotype DX The Role of Oncotype DX Oncotype DX Studies Oncotype DX Logistics Clinical Practice Guidelines Health Insurance Coverage The TAILORx Clinical Trial TAILORx Clinical Trial Objectives Who Is Eligible For TAILORx? TAILORx Insurance Coverage Why Oncotype DX Was Chosen Sponsor Additional Information On TAILORx Contacts Frequently Asked Questions Who Is Eligible For TAILORx? The TAILORx trial is for women with recently diagnosed, early-stage (Stage I or II) breast cancer. The cancer must be: Estrogen receptor-positive and/or progesterone receptor-positive HER2/neu negative Lymph node negative At least 1 cm in size Some women with tumors smaller than 1 cm may be eligible to participate if they have a higher than usual risk of relapse. All participants must be medically appropriate candidates for chemotherapy, and must agree to take chemotherapy if that is the treatment determined by the study (Recurrence Score® > 25) or the study randomization (Recurrence Score between 11 and 25). For eligibility questions please contact ECOG at ecog.tailorx@jimmy.harvard.edu. What's New? August 5, 2008 Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress July 29, 2008 Genomic Health to Announce Second Quarter 2008 Financial Results and Host Conference Call on Tuesday, August 5, 2008

© 2008 Genomic Health, Inc.  All rights reserved. | Home | Contact Us | Privacy | Terms and Conditions |